Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:HUMA News 12 November 2025

Humacyte (HUMA) Q3 2025: Symvess Sales Surge; IND Filed for CABG as Dialysis Data Advance — Nov 12, 2025

Humacyte (HUMA) Q3 2025: Symvess Sales Surge; IND Filed for CABG as Dialysis Data Advance — Nov 12, 2025

Durham, N.C. — November 12, 2025 — Humacyte, Inc. (NASDAQ: HUMA) reported third‑quarter results and a pipeline update this morning, highlighting accelerating Symvess™ sales, new clinical data in dialysis access, and a key regulatory step toward first‑in‑human testing of its coronary bypass graft. GlobeNewswire What Humacyte reported Humacyte posted $753,000 in Q3 revenue—$703,000 from Symvess, the FDA‑approved acellular tissue‑engineered vessel (ATEV) for adult extremity vascular trauma, and ~$100,000 from a collaboration with a large med‑tech partner. Management emphasized a step‑up in VAC approvals and hospital onboarding as the key driver of the sales ramp. GlobeNewswire On profitability, the company recorded
12 November 2025
···

Stock Market Today

City Developments Limited stock: $709 million land bid puts CDL share price in focus for Monday

City Developments Limited stock: $709 million land bid puts CDL share price in focus for Monday

7 February 2026
Singapore, Feb 7, 2026, 15:34 SGT — Market closed. City Developments Limited (CDL) will head into next week with a new catalyst after a CDL-led venture submitted the top bid for a Government Land Sale (GLS) residential site at Tanjong Rhu Road. The offer was S$709.25 million, or about S$1,455 per square foot per plot ratio, ahead of bids that included groups involving Sunway MCL, Sim Lian and GuocoLand. CDL shares slipped 0.6% on Friday to close at S$9.57. For CDL, the tender matters because land bought at that level needs selling prices and costs to line up, or margins
Glencore share price steadies after Rio Tinto walks away — what to watch next week

Glencore share price steadies after Rio Tinto walks away — what to watch next week

7 February 2026
Glencore shares closed up 0.6% at 478.1 pence Friday, rebounding after a 7% drop following the collapse of merger talks with Rio Tinto. The company is expected to announce the sale of its Kazzinc stake soon and has signed a non-binding agreement with Orion for a potential $9 billion deal in the DRC. Investors await Glencore’s full-year results on Feb. 18 for further guidance.
RELX share price slides again as AI fears linger, results next week in focus

RELX share price slides again as AI fears linger, results next week in focus

7 February 2026
RELX closed down 4.6% at 2,145 pence in London on Friday, capping a volatile week ahead of its Feb. 12 full-year results. The company bought back 465,361 shares even as selling continued amid investor concerns over AI risks and pricing power. Peers Wolters Kluwer and Thomson Reuters also faced pressure. Markets await RELX’s outlook for 2026 trading.
Go toTop